Agenus | AGEN - Betriebsergebnis





Betriebsergebnis Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Celldex Therapeutics USD -80.62M 3.81M 2026-06
CSL USD 2.64B 1.97B 2025-12
Eli Lilly USD 12.46B 2.68B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Glaxosmithkline GBP 2.29B 3.08M 2026-03
Incyte USD 700.4M 376.22M 2026-06
Intrexon USD -60.84M 26.62M 2024-06
J&J USD 7.48B 860M 2026-06
Jiangsu Hengrui CNY 1.68B 876.54M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -33.44M 21.34M 2026-03
Merck EUR 1.1B 51M 2026-06
Merck USD 840M 2.72B 2026-06
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Novartis USD 4.75B 515M 2026-06
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 667M 4.32B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Veracyte USD 23.96M 4.88M 2026-06